FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (Nasdaq: MSON) today announced the first of several events to spotlight its world leading therapeutic prostate and kidney cancer medical devices using high intensity focused ultrasound (“HIFU”). The first of these initiatives is the participation with an exposition booth (Hall 16, Booth #5) at the European Association of Urology Conference 2007 in Berlin, Germany, from March 21 through March 24. The European Association of Urology (“EAU”) is the largest scientific urological organization in Europe. The EAU connects 16,000 urologists, urologists-in-training and urological scientists in Europe and worldwide.
